1-year-old Baby Coka nears the tragic end of her battle with a life-threatening intestinal disease

It was only last week when one-year-old Coka’s parents made the heartbreaking decision to stop administering “strong heart medicine” which was helping prolong their baby girl’s life.

The decision was made following their doctor’s advice, after the baby’s heart stopped twice Tuesday night.

Coka’s parents have been keeping a Facebook page named “CoKa.Kona Baby” with updates about the infant’s condition since March, hoping that the Coka’s journey would inspire others to share their stories and raise awareness of intestinal diseases.

Coka, a twin girl, was born prematurely after only 31 weeks of pregnancy (about nine weeks early), and went through three surgeries as a newborn. Whereas her twin sister, Kona, had been born without issues, Coka was diagnosed with necrotizing enterocolitis, a life-threatening intestinal disease affecting premature babies.

Only one-tenth of Coka’s small intestine remains after surgery, requiring her to live on liquids during her long-term hospital stay, while a tube was put in in her chest to drain blood clots.

At around 7 pm Tuesday, the 1-year-old girl Coka’s heart rate suddenly dropped until she flatlined twice, her mother announced on Facebook Wednesday morning. Queen Mary Hospital medical staff said then that the toddler may only have one to two days to live.

Coka’s mother invited their 4,700 Facebook followers to send motivational voice messages for Coka to listen to as she fights through her final days.

On Tuesday, Coka’s mother also wrote: “Love you forever, [we’ll] always remember everything about you.”

Read more: 1-year-old baby who urgently needed liver donation is now on road to recovery

See also  FedEx Express balks at Hong Kong’s new coronavirus quarantine measures, will temporarily relocate aircrew and families to San Francisco

Subscribe to The Coconuts Podcast for top trending news and pop culture from Southeast Asia and Hong Kong every Friday!


Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.